Figure 4.
OS after treatment with navitoclax and ruxolitinib. (A) Kaplan-Meier curve of OS for pooled cohort 1; (B) Kaplan-Meier curve of OS by DIPSS risk for pooled cohort 1. NR, not reached.

OS after treatment with navitoclax and ruxolitinib. (A) Kaplan-Meier curve of OS for pooled cohort 1; (B) Kaplan-Meier curve of OS by DIPSS risk for pooled cohort 1. NR, not reached.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal